{
    "clinical_study": {
        "@rank": "88957", 
        "arm_group": {
            "arm_group_label": "Observational", 
            "description": "Tissue samples are analyzed for tumor factor expression levels by immunohistochemistry."
        }, 
        "brief_summary": {
            "textblock": "This trial studies biomarker expression in tissue samples from patients with bone sarcomas.\n      Studying biomarker in tissue samples from patients with cancer in the laboratory may help\n      doctors identify and learn more about biomarkers related to cancer"
        }, 
        "brief_title": "Biomarker Expression in Tissue Samples From Patients With Bone Sarcomas", 
        "condition": [
            "Localized Osteosarcoma", 
            "Metastatic Osteosarcoma", 
            "Recurrent Osteosarcoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Osteosarcoma", 
                "Sarcoma"
            ]
        }, 
        "detailed_description": {
            "textblock": "STUDY SUBTYPE: Ancillary/Correlative\n\n      OBSERVATIONAL STUDY MODEL: Case-only\n\n      TIME PERSPECTIVE: Retrospective\n\n      BIOSPECIMEN RETENTION: Samples without DNA\n\n      BIOSPECIMEN DESCRIPTION: Tissue samples obtained from Cooperative Human Tissue Network\n      (CHTN)\n\n      STUDY POPULATION DESCRIPTION: Patients enrolled on P9754 and AOST0121 clinical trials\n\n      SAMPLING METHOD: Non-probability sample\n\n      PRIMARY OBJECTIVES:\n\n      I. To determine if there is differential expression of tumor factor (TF) among patients with\n      osteosarcoma.\n\n      II. To determine if there is an association between overall survival and disease free\n      survival and the extent of TF expression.\n\n      III. To determine if TF expression correlates with presence of gross metastatic disease at\n      presentation, and development of subsequent metastases.\n\n      OUTLINE:\n\n      Tissue samples are analyzed for tumor factor expression levels by immunohistochemistry."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Tissue samples from patients with osteosarcomas obtained from the CHTN:\n\n               -  P9754 clinical trial for patients with non-metastatic osteosarcoma\n\n               -  AOST0121 clinical trial for patients with metastatic or recurrent osteosarcoma"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "39 Years", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Tissue samples from patients with osteosarcomas obtained from the CHTN that participated\n        in either study P9754 clinical trial for patients with non-metastatic osteosarcoma or\n        AOST0121 clinical trial for patients with metastatic or recurrent osteosarcoma"
            }
        }, 
        "enrollment": {
            "#text": "34", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01807052", 
            "org_study_id": "AOST10B2", 
            "secondary_id": [
                "NCI-2013-00112", 
                "COG-AOST10B2"
            ]
        }, 
        "intervention": {
            "arm_group_label": "Observational", 
            "description": "Correlative studies", 
            "intervention_name": "laboratory biomarker analysis", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 6, 2013", 
        "location": {
            "contact": {
                "email": "mark.ranalli@nationwidechildrens.org", 
                "last_name": "Mark A. Ranalli", 
                "phone": "614-722-3563"
            }, 
            "facility": {
                "address": {
                    "city": "Arcadia", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "91006-3776"
                }, 
                "name": "Children's Oncology Group"
            }, 
            "investigator": {
                "last_name": "Mark A. Ranalli", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Observational - Tissue Factor Expression in Bone Sarcomas", 
        "overall_official": {
            "affiliation": "Children's Oncology Group", 
            "last_name": "Mark Ranalli", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2100", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Estimated in the analytic population as the number of samples in the population in which such expression is noted divided by 33. An assessment of the precision of such estimates will be provided by an exact binomial confidence interval. Comparison of normalized TF expression in non-metastatic versus metastatic patients will be done using the two-sample t-test.", 
            "measure": "Prevalence of high TF expression", 
            "safety_issue": "No", 
            "time_frame": "1 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01807052"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Children's Oncology Group", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Children's Oncology Group", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2009", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "March 2013"
    }
}